logo

DARE

Dare Bioscience·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.06 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is DARE a Buy, Sell, or Hold?
  • Based on a composite score of 4.06/10, we rate DARE as a Netural. Our analysis breaks down into 2.58/10 for Fundamentals, 1.01/10 for Technicals, and 6.32/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is DARE undervalued or overvalued?
Technical Analysis of DARE?
What is the analyst consensus for DARE?